The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Advancing Nuclear Medicine through Innovation
National Institute of Biomedical Imaging and Bioengineering (NIBIB) Perspective on the National Academies “State of the Science in Nuclear Medicine” Study, William Heetderks, M.D., Associate Director for Extramural Science Programs, NIBIB, NIH
Presentation to NAS Committee on “State of the Science in Nuclear Medicine,” Michael Welch, Ph.D., Professor of Radiology, Washington University School of Medicine, on behalf of the Society of Nuclear Medicine
Society of Radiopharmaceutical Sciences, William Eckelman, Ph.D., Adjunct Professor of Radiology, University of California at San Diego, on behalf of the Society of Radiopharmaceutical Sciences
State of the Science in Nuclear Medicine: IEEE Perspective, William Moses, Ph.D., Senior Staff Scientist in the Life Sciences Division at Lawrence Berkeley National Laboratory, on behalf of the IEEE Nuclear & Plasma Sciences Society
Issues Affecting the Future of Nuclear Medicine, Roy Brown, Senior Director, Federal Affairs, Council on Radionuclides and Radiopharmaceuticals
Perspectives from the Society of Molecular Imaging, Thomas Budinger, M.D., Ph.D., Professor of Radiology, University of California at San Francisco, on behalf of the Society of Molecular Imaging
State of the Science in Nuclear Medicine: A Physician-Scientist’s Perspective, Richard Wahl, M.D., Henry N. Wagner, Jr., Professor of Nuclear Medicine, Johns Hopkins University, on behalf of the Academy of Radiology Research
A.2 SECOND MEETING, AUGUST 24–25, 2006,WASHINGTON, D.C.
The objective of the second meeting was to gather information on the state of the science in radiopharmaceuticals and issues surrounding isotope availability to the nuclear medicine community (charges 1 and 3 of the statement of task). The following is the list of topics and speakers who presented during the open session:
NCI’s Current and Future Commitment to Translational Research: an Interim Report of the Translational Research Working Group, Ernest Hawk, M.D., M.P.H., Director of the Office of Centers, Training, & Resources in the Office of the Director, NCI, NIH
Radiopharmaceutical Chemistry: Future Needs and Directions, Michael Welch, Ph.D., Professor of Radiology, Molecular Biology and Pharmacology, and Biomedical Engineering, and Co-Director of the Division of Radiological Sciences, Washington University Medical School
